Eli Lilly Weight Loss Pill Approval: Food Industry Shake-Up 2025
FDA fast-tracks Eli Lilly’s orforglipron pill for obesity, delivering 12-15% weight loss in trials—poised for 2026 launch amid GLP-1 boom, forcing snack giants to slash calories and reformulate. Reuters reports approval accelerates “product overhauls” as 40% U.S. adults seek affordable alternatives to $1,000/month injectables like Wegovy. For dieters searching “Eli Lilly weight loss pill FDA […]
Eli Lilly Weight Loss Pill Approval: Food Industry Shake-Up 2025 Read More »
